Press Releases

Date Title View
Toggle SummaryOctober 15, 2018 GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018
CARLSBAD, Calif. , Oct. 15, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Monday, October 29, 2018. Management will hold a conference call to review the Company's financial
View HTML
Toggle SummaryOctober 2, 2018 GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels
Submissions Now Complete for All Three ePlex Molecular Multiplex Panels Designed for the Diagnosis and Management of Bloodstream Infections That Can Lead to Sepsis CARLSBAD, Calif. , Oct. 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated,
View HTML
Toggle SummaryJuly 30, 2018 GenMark Diagnostics Reports Second Quarter 2018 Results
CARLSBAD, Calif. , July 30, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the second quarter ended June 30, 2018 .
View HTML
Toggle SummaryJuly 25, 2018 GenMark Diagnostics to Present at the Canaccord Genuity 38th Annual Growth Conference
CARLSBAD, Calif. , July 25, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany , will participate in the Canaccord Genuity 38th
View HTML
Toggle SummaryJuly 16, 2018 GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018
CARLSBAD, Calif. , July 16, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, July 30, 2018. Management will hold a conference call to review the Company's financial performance
View HTML
Toggle SummaryJune 28, 2018 GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel
First of Three ePlex Molecular Multiplex Panels for the Diagnosis and Management of Bloodstream Infections That Can Lead to Sepsis CARLSBAD, Calif. , June 28, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing
View HTML
Toggle SummaryJune 6, 2018 GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
CARLSBAD, Calif. , June 06, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany , will present at the William Blair 38th Annual
View HTML
Toggle SummaryMay 2, 2018 GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
CARLSBAD, Calif. , May 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany , will present at the Bank of America Merrill Lynch
View HTML
Toggle SummaryMay 1, 2018 GenMark Diagnostics Reports First Quarter 2018 Results
CARLSBAD, Calif. , May 01, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the first quarter ended March 31, 2018 .
View HTML
Toggle SummaryApril 17, 2018 GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018
CARLSBAD, Calif. , April 17, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 1, 2018. Management will hold a conference call to review the Company's financial performance
View HTML